(2)Pursuant to Commission Implementing Regulation (EU) 2024/2699note, the European Medicines Agency is to provide the Commission acting as secretariat of the Coordination Group (‘the HTA secretariat’) with information on all medical devices for which the expert panels provided a scientific opinion or their views no later than 15 days after the end of each quarter, pertaining to that quarter.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.